Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City

Drug and Alcohol Dependence

Volumn 153, Issue , 2015, Pages 72-77

  Lewis, Crystal Fuller ^a,b   Rivera, Alexis V ^c   Crawford, Natalie D ^d   DeCuir, Jennifer ^c,e   Amesty, Silvia ^c,e  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine   (United States)

^d EMORY UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

HIV prevention; Persons who inject drugs (PWID); Pharmacies; Risk behavior; Structural interventions

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; CONTROLLED STUDY; DEVICE SAFETY; DRUG SELF ADMINISTRATION; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MARKETING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; SEX DIFFERENCE; SYRINGE; UNITED STATES; COMMERCIAL PHENOMENA; COMPLICATION; ECONOMICS; HARM REDUCTION; HIV INFECTIONS; MIDDLE AGED; PHARMACY; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADULT; COMMERCE; COMMUNITY PHARMACY SERVICES; FEMALE; HARM REDUCTION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 84937639385     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.006     Document Type: Article

References (19)

1. Amesty S., Blaney S., Crawford N.D., Rivera A.V., Fuller C. Pharmacy staff characteristics associated with support for pharmacy-based HIV testing. J. Am. Pharm. Assoc. 2012, 52(1-9):472-479.
2. Coffin P.O., Blaney S., Fuller C., Vadnai L., Miller S., Vlahov D. Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians. Am. J. Drug Alcohol Abuse 2006, 32:1-6.
3. Cooper H.L., Bossak B.H., Tempalski B., Friedman S.R., Des Jarlais D.C. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J. Urban Health 2009, 86:929-945.
4. Crawford N.D., Amesty S., Rivera A.V., Harripersaud K., Turner A., Fuller C.M. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City. Am. J. Public Health 2013, 103:1579-1582.
5. Crawford N.D., Amesty S., Rivera A.V., Harripersaud K., Turner A., Fuller C.M. Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users. Health Educ. Behav. 2014, 41:397-405.
6. Crawford N.D., Blaney S., Amesty S., Rivera A.V., Turner A.K., Ompad D.C., Fuller C.M. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J. Urban Health 2011, 88:176-185.
7. Des Jarlais D.C., Arasteh K., Hagan H., McKnight C., Perlman D.C., Friedman S.R. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am. J. Public Health 2009, 99(Suppl. 2):S445-S451.
8. Fuller C.M., Ahern J., Vadnai L., Coffin P.O., Galea S., Factor S.H., Vlahov D. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J. Am. Pharm. Assoc. (Wash.) 2002, 42:S77-S82.
9. Fuller C.M., Galea S., Caceres W., Blaney S., Sisco S., Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am. J. Public Health 2007, 97:117-124.
10. Hammett T.M., Phan S., Gaggin J., Case P., Zaller N., Lutnick A., Kral A.H., Fedorova E.V., Heimer R., Small W., Pollini R., Beletsky L., Latkin C., Des Jarlais D.C. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv. Res. 2014, 14:261.
11. Institute of Medicine Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence 2006, National Academies Press, Washington, DC.
12. Kottiri B.J., Friedman S.R., Neaigus A., Curtis R., Des Jarlais D.C. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J. Acquir. Immune Defic. Syndr. 2002, 30:95-104.
13. Lutnick A., Case P., Kral A.H. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings. J. Urban Health 2012, 89:354-364.
14. Meyerson B.E., Ryder P.T., von Hippel C., Coy K. We can do more than just sell the test: pharmacist perspectives about over-the-counter rapid HIV tests. AIDS Behav. 2013, 17:2109-2113.
15. New York Academy of Medicine New York State Expanded Syringe Access Demonstration Program Evaluation: Evaluation Report to the Governor and the New York State Legislation, New York City 2003.
16. Rivera A.V., Blaney S., Crawford N.D., White K., Stern R.J., Amesty S., Fuller C. Individual- and neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program. J. Am. Pharm. Assoc. 2010, 50:580-587.
17. Rudolph A.E., Standish K., Amesty S., Crawford N.D., Stern R.J., Badillo W.E., Boyer A., Brown D., Ranger N., Orduna J.M., Lasenburg L., Lippek S., Fuller C.M. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ. Prev. 2010, 22:238-251.
18. Williams C., Eisenberg M., Becher J., Davis-Vogel A., Fiore D., Metzger D. Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. J. Acquir. Immune Defic. Syndr. 2013, 63(Suppl. 1):S90-S94.
19. Zaller N.D., Yokell M.A., Green T.C., Gaggin J., Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst. Use Misuse 2013, 48:590-599.